InstaPill Private Limited
June 23, 2026
Theater 1
Type: Company Presentation
Focus Area:
Multiple Therapeutics
InstaPill® is a globally recognized CDMO specializing in orally disintegrating tablets using our proprietary InstaPill® technology platform. Our facility in Bengaluru, India, houses experienced pharma professionals who have successfully developed and manufactured products registered and distributed in over 50 countries, and has installed capacity of 300 million tablets.
With a commitment to innovation and compliance, our facility has approvals from the FDA, EU, Health Canada, MHRA, and TGA.
From early formulation through regulatory approvals and commercial supply, our integrated services are designed to reduce time to market, enhance product performance, and ensure consistent quality at scale.
Company HQ City:
Bangalore
Company HQ State:
Karnataka
Company HQ Country:
India
Year Founded:
2017
Lead Product in Development:
Multiple small molecule and peptide products are under development where global or regional partners are being sought.
CEO
Ankit Gupta
Development Phase of Lead Product
Multiple Products in Market
When you expect your next catalyst update?
June 2026
What is your next catalyst (value inflection) update?
Establishment of both a UK based R&D center and addition of US commercial manufacturing site.
Primary Speaker
)
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}